FDA scientists pushed back on plan to ease access to unproven peptides

Most FDA scientific staff opposed a US plan to make unproven peptide drugs easier to obtain, according to six people familiar with the policy. Favoured by Health Secretary Robert F Kennedy Jr, the document posted by the health department covers injectable peptides marketed in the wellness industry for building muscle, healing injuries and boosting energy. Agency scientists reportedly had limited input.